| Brand Name: | Adnor |
| Generic: | Doxepin (Oral) |
| Weight: | 75 mg |
| Type: | Capsule |
| Therapeutic Class: | Tricyclic & related anti-depressant drugs |
| Manufacturer: | Apex Pharmaceuticals Ltd. |
| Price: | 7.00 |
| Last Updated: | 2020-11-20 18:15:00 |
Adnor Capsule contains Doxepin (Oral). Adnor uses:
Anxiety disorders, Depression, Insomnia.
Adnor Capsule contains Doxepin (Oral) 75 mg. Adnor doses:
Adult: As hydrochloride: Initially, 75 mg daily adjusted according to response; up to 300 mg daily in severely depressed patients; 25-50 mg daily in mildly affected patients. Total daily dose >100 mg should be given in divided doses.
May be taken with or without food.
Sedation, fatigue, weakness, lethargy, Dry mouth, Constipation, Blurred vision, Headache, Agitation, Insomnia, Anxiety, Nausea, vomiting, Sweating, Confusion, extrapyramidal symptoms (EPS), dizziness, paresthesia, Orthostatic hypotension, ECG changes, tachycardia, Increased LFTs, Tinnitus, Sexual dysfunction, Rash, Seizure, Agranulocytosis, Thrombocytopenia, Eosinophilia.
Doxepin inhibits serotonin and norepinephrine re-uptake by the presynaptic neuronal membrane increasing its synaptic conc in the CNS.
Epilepsy, CV disease, pregnancy, history of urinary retention, glaucoma; gradual withdrawal. May impair ability to drive or operate machinery.
Methylphenidate may increase plasma doxepin levels. Potentially Fatal: Potentiates hypertensive action of sympathomimetics. Increased anticholinergic effects with MAOIs. Additive CNS effects with anticholinergics, CNS depressants and alcohol.
Category C: Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the fetus.
Hypersensitivity; mania, glaucoma, neonates (topical); lactation.
Store at 15-30°C.
Adnor Capsule price in Bangladesh 7.00